Trial
NCT03297294
Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN)
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
Novartis Pharmaceuticals
Collaborators
—
Condition
Painful Diabetic Neuropathy
Intervention
EMA401
Why stopped
Study was terminated due to animal toxicity data
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-10-08